Zoster vaccine live (Merck Sharp & Dohme)

N/A

Report date: 2026/03/14 20:00:17

Base Information

Drug NameZoster vaccine live (Merck Sharp & Dohme)
Drug Alias NameZostavaxV-211
ClassificationVaccines > Development/production technology > Live attenuated vaccineVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsPsoriasisCrohn DiseaseArthritis, Rheumatoid +[11
Global Approved IndicationsHerpes Zoster
Approved Indications in ChinaN/A
Original Approved Country/TerritoryEU
Original Approved Date2006/05/19
Country/TerritoryUnited StatesAustraliaEU +[4
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesMerck Sharp & Dohme Corp
China Registration ClassN/A

Develop Information

Active IndicationsNeuroblastomaOsteosarcoma
Inactive IndicationsPsoriasisCrohn DiseaseArthritis, Rheumatoid +[9

Other Information

ATC CodeJ07BK02
Related LinksWikipedia